No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
NextCure to Present at 24th Annual Needham Virtual Healthcare Conference
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
H.C. Wainwright Maintains NextCure(NXTC.US) With Buy Rating, Maintains Target Price $3
Optimistic Buy Rating for NextCure Driven by Promising Developments in LNCB74 for Endometrial Cancer
Nextcure Faces Delisting Risk Amid Nasdaq Compliance Struggles
NextCure Analyst Ratings